[ Price : $8.95]
FDA reports on enforcement actions taken against 17 classes of unapproved new drugs.[ Price : $8.95]
The HHS inspector general says it has recovered about $6.9 billion through FY 2012 investigations and audits.[ Price : $8.95]
CDER director Janet Woodcock says Howard Sklamberg will become director of the Centers Office of Compliance early next year.[ Price : $8.95]
Endo asks FDA to act quickly in determining that its non-crush resistant Opana ER was withdrawn from the market for reasons of saf...[ Price : $8.95]
Forest Laboratories submits an NDA for cariprazine, indicated for treating schizophrenia and manic or mixed episodes associated wi...[ Price : $8.95]
FDA rejects a Public Citizen petition seeking a boxed warning and other changes to labeling for Sucampo and Takedas constipation d...[ Price : $8.95]
FDAs Minneapolis District Office warns InCentral Medical about Quality System violations in its manufacturing of the InTone female...[ Price : $8.95]
FDA approves an Avaxia Biologics IND for AVX-470 for treating of ulcerative colitis.